Imatinib Withdrawn Phase 1 Trials for Healthy Volunteers Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02129166Explore the Synergy of Combination TKI Therapy